<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-id><journal-title-group><journal-title>Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-title></journal-title-group><issn publication-format="electronic">1990-472X</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">7517</article-id><article-id pub-id-type="doi">10.18499/1990-472X-2022-0-87-4-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>INVESTIGATION OF D-DIMER VALUES IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE JOINTS WHO HAVE UNDERGONE CORONAVIRUS DISEASE COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vasilyeva</surname><given-names>L. V</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Evstratova</surname><given-names>E. F</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Suslova</surname><given-names>E. Yu</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gosteva</surname><given-names>E. V</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Latisheva</surname><given-names>M. N</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Voronezh State Medical University</aff><pub-date date-type="epub" iso-8601-date="2022-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2022</year></pub-date><issue>87</issue><fpage>4</fpage><lpage>8</lpage><history><pub-date date-type="received" iso-8601-date="2022-04-06"><day>06</day><month>04</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022, Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>26 patients, 20 women and 6 men, 64,2±2,2 years old with ostearthritis of the knee joints (main group) who had a new coronavirus infection COVID-19 of mild severity 3 months before the examination were examined. The quantitative indicators of D - dimer and joint pain were evaluated on a visual analog scale (VAS). Significantly higher D-dimer values were shown in the group of patients who had COVID-19, correlated with joint pain and signs of inflammation when compared with patients who did not have the new COVID-19 coronavirus infection.</abstract><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>D-dimer</kwd><kwd>joint pain</kwd><kwd>COVID-19</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Д-димер</kwd><kwd>боль в суставах</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Насонов Е.Л. Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. / Е.Л. Насонов. - Текст : непосредственный.// Клин.фармакол. тер. - 2021. - № 1. - С. 24-29. @@Nasonov E.L. Coronavirus disease 2019 (COVID-19) and immunoinflammatory rheumatic diseases. / E.L. Nasonov. - Text: direct.// Clin.pharmacol. ter.. - 2021. - No. 1. - Р. 24-29.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Дистанционные технологии при коррекции боли в суставах у пациентов с остеоартритом в условиях COVID-19 / Л.В. Васильева Е.Ф. Евстратова, Е.П. Карпухина, Е.Ю. Суслова. - Текст : непосредственный. // Ж.Инфектологии. Том 13, №1, 2021. Приложение 1. С.-Пб. 3-4 февраля 2021. - С.25. @@Remote technologies for the correction of joint pain in patients with osteoarthritis under conditions of COVID-19 / L.V. Vasilyeva E.F. Evstratova, E.P. Karpukhina, E.Yu. Suslova. - Text : direct. // J. Infectology. Volume 13, No. 1, 2021. Appendix 1. St. Petersburg. February 3-4, 2021. - P.25.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19 Prof Beverley Hunt OBE Dr Andrew Retter Dr Claire McClintock 25th March 2020.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Белов Б.С. COVID-19: новый вызов ревматологам. / Б.С. Белов, АЕ. Каратеев. - Текст : непосредственный. // Современная ревматология. - 2020. - № 14(2). - С. 110-116. @@Belov B.S. COVID-19: a new challenge for rheumatologists. / B.S. Belov, AE. Karateev. - Text : direct. // Modern rheumatology. - 2020. - No. 14(2). - Р. 110-116.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Метаанализ клинических исследований эффективности лечения остеоартита препаратом Хондрогард. / И.Ю. Торшин, А.М. Лила, А.В. Наумов [и др.] - Текст : непосредственный. // Фармакоэкономика. Современная Фармакоэкономика и Фармакоэпидемиология. - 2020. - 13 (4). - С. 17-28. @@Meta-analysis of the results of studies of the results of treatment of osteoarthritis with Chondrogard. / I.Yu. Torshin, A.M. Leela, A.V. Naumov [and others] - Text: direct. // Pharmacoeconomics. Pharmacoeconomics and Pharmacoepidemiology. - 2020. - 13 (4). - Р. 17-28.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Бекетова Т.В. Обзор рекомендаций Европейской антиревматической лиги (EULAR), рассмотренных в 2018 г. / Т.В. Бекетова. - Текст : непосредственный. // Современная ревматология. - 2019. - №13(2). -С.22-24. @@Beketova T.V. Antirheumatic League Detection Review (EULAR), 2018 review / T.V. Beketova. - Text : direct. // Modern rheumatology. - 2019. - No. 13 (2). -Р.22-24.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020;10.1001/jama.2020.4326.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Постковидный синдром: в центре внимания скелетно-мышечная боль. / А.Е. Каратеев, В.Н. Амирджанова, Е.Л. Насонов [и др.] - Текст : непосредственный. //Научно-практическая ревматология. -2021.- №59(3).-С.255-262. @@Postcovid syndrome: musculoskeletal pain in focus. / A.E. Karateev, V.N. Amirdzhanova, E.L. Nasonov [and others] - Text: direct. // Scientific and practical rheumatology. -2021.- No. 59 (3).- P. 255-262.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Российское научное медицинское общество. Медицинская реабилитация больных перенесших COVID-19 инфекцию: методические рекомендации / Малявин А.Г, Адашева Т.В., Бабак С.Л., Насонов [и др.] -. ПРОЕКТ. Москва. 2020. - 65с. Текст : непосредственный. @@Russian Scientific Medical Society. Medical rehabilitation of patients with COVID-19 infection: guidelines / Malyavin A.G., Adasheva T.V., Babak S.L., Nasonov [et al.] - . PROJECT. Moscow. 2020. - 65р. Text: direct.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации МЗ РФ. Версия 7 03.06.2020 210с. @@Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Temporary guidelines of the Ministry of Health of the Russian Federation. Version 7 06/03/2020 210р.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic.www.escardio.org</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Соловьева И.В. Системный подход для решения задач клинико-диагностической лаборатории / И.В. Соловьева 22с. - Текст : непосредственный. @@Solovieva I.V. System approach for solving problems of clinical diagnostic laboratory / I.V. Solovyov 22p. - Text : direct.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Соловьева И.В. Д-димер: клиническое значение для пожилых пациентов / И.В. Соловьева - Текст : непосредственный.// // Лабораторная служба.- 2017.- № 1.- С. 14-22. @@Solovieva I.V. D-dimer: clinical significance for sick patients / I.V. Solovieva - Text: direct.// // Laboratory service.- 2017.- No. 1.- P. 14-22.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Righini M., Perrier A., De Moerloose P., Bounameaux H. D-Dimer for venous thromboembolism diagnosis: 20 years later. J //Thromb Haemost.- 2008.-6.-P. 1059-1071. Д-димер и тромбозы. @@Righini M., Perrier A., De Moerloose P., Bounameaux H. D-Dimer for venous thromboembolism diagnosis: 20 years later. J //Thromb Haemost.- 2008.-6.-P. 1059-1071. D-dimer and thrombosis.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Сафиуллина С.И. Рекомендации по профилактике и коррекции тромботических осложнений при COVID-19 / С.И. Сафиуллина, Р.И. Литвинов. - Текст : непосредственный.// Казанский мед. ж.- 2020.- №101 (4).-С. 485-488. @@Safiullina S.I. Recommendations for the prevention and correction of thrombotic complications in COVID-19 / S.I. Safiullina, R.I. Litvinov. - Text: direct.// Kazan honey. j.- 2020.- №101(4).-Р. 485-488.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Тромботические заболевания и состояния - диагностика и контроль антикоагулянтной терапии / А.Л. Мелкумян, А.Л. Берковский, С.А. Васильев [и др.] - Текст : непосредственный. // Медицинский Совет. -2020.-№21.-С.256-266. @@Thrombotic diseases and conditions - diagnosis and control of anticoagulant therapy / A.L. Melkumyan, A.L. Berkovsky, S.A. Vasiliev [and others] - Text: direct. // Medical advice. -2020.-No.21.-P.256-266.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Darzi AJ, Karam SG, Charide R et. Prognostic factors for VTE and Bleeding in Hospitalized Medical Patients: a systematic review and meta-analysis. Blood. 2020 Feb 24. pii: blood.2019003603. doi: 10.1182/blood.2019003603. [Epub ahead of print]</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Юпатов В.Д. COVID19-ассоциированная коагулопатия: спорные и нерешенные вопросы / В.Д. Юпатов, Е.Ю. Пономарева - Текст : непосредственный. // Республиканская научно-практическая конференция «Инфекционные аспекты в клинике внутренних болезней» Донецк 02.04. -2021.-С.-23-25 @@Yupatov V.D. COVID19-associated coagulopathy: controversial and unresolved issues / V.D. Yupatov, E.Yu. Ponomarev - Text: direct. // Republican scientific-practical conference "Infectious aspects in the clinic of internal diseases" Donetsk 02.04. -2021.-Р.-23-25</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>World Health Organization. Coronavirus Disease (COVID-2019). Situation Reports (World Health Organization, 2020).</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Насонов Е.Л. Коронавирусная болезнь 2019 (COVID-19): размышления ревматолога / Е.Л. Насонов - Текст : непосредственный. // Научно-практическая ревматология. -2020.- №58(2).-С.123-132. @@Nasonov E.L. Coronavirus disease 2019 (COVID-19): reflections of a rheumatologist / E.L. Nasonov - Text: direct. // Scientific and practical rheumatology. -2020.- No. 58(2).- Р.123-132.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Насонов Е.Л. Коронавирусная болезнь 2019 (COVID-19) и аутоиммунитет / Е.Л. Насонов - Текст: непосредственный. // Научно-практическая ревматология. -2021.- №59(1).- С.5-30. @@Nasonov E.L. Coronavirus disease 2019 (COVID-19) and autoimmunity / E.L. Nasonov - Text: direct. // Scientific and practical rheumatology. -2021.- No. 59(1).- P.5-30.</mixed-citation></ref></ref-list></back></article>
